Neuland Laboratories Sustainability Profile
Neuland Laboratories Limited, commonly referred to as Neuland Labs, is a prominent player in the pharmaceutical industry, headquartered in Hyderabad, India. Founded in 1984, the company has established itself as a leading manufacturer of active pharmaceutical ingredients (APIs) and intermediates, catering to both domestic and international markets. With a strong focus on quality and innovation, Neuland Labs offers a diverse range of products, including custom synthesis and contract manufacturing services. The company is renowned for its expertise in complex molecules and has achieved significant milestones, such as obtaining multiple regulatory approvals from global health authorities. Neuland Labs is well-positioned in the market, recognised for its commitment to sustainability and customer-centric solutions. Its strategic operational regions extend across North America, Europe, and Asia, making it a trusted partner for pharmaceutical companies worldwide.
DitchCarbon Score
How does Neuland Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Neuland Laboratories's score of 65 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Neuland Laboratories's reported carbon emissions
In 2024, Neuland Laboratories reported total greenhouse gas emissions of approximately 57,000,000 kg CO2e, comprising 22,961,440 kg CO2e from Scope 1, 31,406,360 kg CO2e from Scope 2, and 3,036,820 kg CO2e from Scope 3 emissions. This reflects a significant reduction from 2023, where emissions were about 54,000,000 kg CO2e, with Scope 1 at 27,442,350 kg CO2e, Scope 2 at 27,245,080 kg CO2e, and Scope 3 at 5,406,000 kg CO2e. Neuland Laboratories has committed to ambitious climate targets, having signed the Science Based Targets initiative (SBTi) to achieve net-zero emissions across all scopes by 2050. Near-term targets include a 58.8% reduction in absolute Scope 1 and 2 emissions by FY2034 from a FY2024 baseline, and a 63.8% reduction in Scope 3 emissions per ton of product manufactured within the same timeframe. Additionally, the company aims to reduce Scope 1 emissions by 30% and Scope 2 emissions by 25% from 2020 levels by 2030. The company has also implemented initiatives to lower coal consumption at its manufacturing facilities, which directly contributes to reducing Scope 1 emissions. Neuland Laboratories is actively working towards its climate commitments, demonstrating a strong commitment to sustainability in the pharmaceutical sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 21,134,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 19,598,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
How Carbon Intensive is Neuland Laboratories's Industry?
How Carbon Intensive is Neuland Laboratories's Location?
Neuland Laboratories's Scope 3 Categories Breakdown
Neuland Laboratories's Scope 3 emissions, which decreased by 44% last year and decreased by approximately 48% since 2021, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 5% of total emissions under the GHG Protocol, with "Upstream Transportation & Distribution" being the largest emissions source at 33% of Scope 3 emissions.
Top Scope 3 Categories
Neuland Laboratories's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Neuland Laboratories has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
